Bronchial Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Keywords
Chronic Obstructive Pulmonary Disease (COPD), Intervention, Mobile Application, Bronchial asthma, Adherence, Inhaled therapy
Brief summary
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
Detailed description
Nonadherence to inhaled therapy is a significant problem in patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD), which has a negative impact on the patients´ health as well as increases the healthcare system costs. The present project focuses on multimodal assessment of adherence to inhaled therapy in patients with BA and COPD and knowledge and skills related to inhalation technique in healthcare professionals caring for patients with BA and COPD at different levels of care using our simple and validated Five Steps Assessment (FSA) tool. This is a multicenter prospective observation-interventional study planning to include 800 outpatients treated in health care facilities and nursing home residents and 200 health care professionals. During the project, a mobile/web-based app using artificial intelligence applicable to patients and healthcare professionals will be developed, implemented, and validated. Interventions (e.g., training on correct inhalation technique, educational materials, telephone/online contact, mobile/web app) to promote adherence to inhaled therapy in BA and COPD will be developed and implemented in patients. In the case of healthcare professionals, interventions (e.g., course including e-learning, mobile/web app) will be directed at increasing knowledge and skills related to inhalation technique. The impact of the interventions on patients and healthcare professionals will be verified by repeated follow-up. To be able to assess the improvement in adherence to inhaled therapy in depth, clinical and laboratory biomarkers potentially indicating the stability of COPD and BA will be measured. The outputs of the project may help to identify patients with given diagnoses at high risk of medication nonadherence and to offer simple, effective, and widely available interventions to promote medication adherence as well as to educate healthcare professionals and thereby to improve patient care.
Interventions
OTHEREducation in inhalation technique
Education in inhalation technique
Sponsors
Ministry of Health, Czech Republic
University Hospital Hradec Kralove
University of Hradec Hralove
Charles University, Czech Republic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
PATIENTS Inclusion Criteria: 1. signed informed consent, 2. age ≥ 18 years, 3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria, 4. ability to cooperate, 5. at least 8 weeks without exacerbation, 6. use of a particular inhaler for at least 3 months.
Exclusion criteria
1. pre-terminal/terminal stage of any disease, 2. uncooperative patient, 3. significant limitation of mobility or cognitive functions. HEALTHCARE PROFESSIONALS Inclusion Criteria: 1. signed informed consent, 2. completed education in medicine, pharmacy, or nursing, 3. more than one year of working experience, 4. care for patients taking inhaled therapy for BA/COPD.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Adherence to inhaled treatment measured by the Medication Adherence Report Scale (MARS). | Assessment of adherence to inhaled treatment within 12 months. | Assessment of adherence to inhaled treatment measured by patients' behavior towards inhaled treatment and a number of mistakes in inhalation technique. |
| Adherence to inhaled treatment measured by Five Steps Assessment (FSA). | Assessment of adherence to inhaled treatment within 12 months. | Assessment of adherence to inhaled treatment measured by patients' behavior towards inhaled treatment and a number of mistakes in inhalation technique. |
| Critical knowledge measured by our own questionnaire in healthcare professionals caring for patients with COPD and bronchial asthma. | Critical knowledge related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months | Assessment of Critical knowledge by questions on correct usage of particular inhalation systems related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma. |
| Critical skills related to inhalation techniques measured by FSA in healthcare professionals caring for patients with COPD and bronchial asthma. | Critical skills related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma within 12 months. | Assessment of critical skills measured by a number of mistakes in inhalation technique in particular inhalation systems related to inhalation techniques in healthcare professionals caring for patients with COPD and bronchial asthma. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessment of clinical (e.g. CAT in patients with COPD) and laboratory (e.g. white blood cell count) biomarkers potentially indicating the stability of COPD and bronchial asthma in a subgroup of patients. | Assessment of clinical and laboratory biomarkers potentially indicating the stability of COPD and bronchial asthma within 12 months. | Changes in relevant clinical (COPD Assessment Test - CAT in patients with COPD; Asthma Control Test - ACT in patients with bronchial asthma; exacerbation frequency, and rescue medication usage) and laboratory (e.g. white blood cell count, C-reactive protein, FeNO level) biomarkers potentially indicating the stability of COPD and bronchial asthma in a subgroup of patients will be assessed. |
Countries
Czechia
Contacts
Primary ContactJosef Malý, Assoc. Prof. PhD.
Outcome results
None listed